The affiliation of very poor differentiation and late tumor stage with DACH1 methylation indicates that DACH1 methylation could provide as esophageal most cancers prognostic marker
The expression of DACH1 was diminished in breast, prostate, lung, endometrial, colorectal and hepatocellular carcinoma, but it was elevated in ovarian most cancers. DACH1 expression was controlled by promoter location…